Rebuzzi, Antonio Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 3.574
EU - Europa 3.534
AS - Asia 2.359
SA - Sud America 437
AF - Africa 57
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 9.978
Nazione #
US - Stati Uniti d'America 3.508
DE - Germania 1.652
SG - Singapore 1.144
CN - Cina 724
SE - Svezia 482
BR - Brasile 366
UA - Ucraina 293
IT - Italia 237
FR - Francia 236
GB - Regno Unito 169
IE - Irlanda 131
ID - Indonesia 91
IN - India 87
VN - Vietnam 87
FI - Finlandia 75
RU - Federazione Russa 73
TR - Turchia 50
PL - Polonia 47
BE - Belgio 36
AR - Argentina 34
MX - Messico 29
NL - Olanda 28
BD - Bangladesh 27
HK - Hong Kong 23
CA - Canada 21
JP - Giappone 21
IR - Iran 20
ZA - Sudafrica 19
AT - Austria 17
IQ - Iraq 16
MA - Marocco 12
EC - Ecuador 10
ES - Italia 10
AU - Australia 8
CL - Cile 8
EG - Egitto 8
AE - Emirati Arabi Uniti 7
PK - Pakistan 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
CR - Costa Rica 6
KR - Corea 6
LT - Lituania 6
CH - Svizzera 5
CO - Colombia 5
EU - Europa 5
RO - Romania 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GR - Grecia 4
JO - Giordania 4
KE - Kenya 4
LV - Lettonia 4
PE - Perù 4
PY - Paraguay 4
AL - Albania 3
BG - Bulgaria 3
BY - Bielorussia 3
IL - Israele 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
PA - Panama 3
TN - Tunisia 3
VE - Venezuela 3
XK - ???statistics.table.value.countryCode.XK??? 3
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
CY - Cipro 2
IS - Islanda 2
LB - Libano 2
NP - Nepal 2
PH - Filippine 2
PS - Palestinian Territory 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LY - Libia 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
Totale 9.978
Città #
Chandler 736
Singapore 554
Ashburn 315
San Mateo 164
Jacksonville 161
New York 157
Dublin 130
Beijing 126
Nanjing 116
Ann Arbor 100
Nürnberg 94
Jakarta 83
Wilmington 79
Los Angeles 74
Dearborn 62
Munich 62
Boston 60
Marseille 58
Houston 56
Lawrence 53
Nanchang 51
Milan 47
Cattolica 46
Moscow 43
Frankfurt am Main 42
Seattle 42
Hefei 40
Dallas 39
Woodbridge 39
Chicago 37
Brussels 36
Zhengzhou 35
Izmir 34
Fairfield 31
Lancaster 31
Redwood City 30
Buffalo 29
Kraków 28
São Paulo 27
Hanoi 25
Ho Chi Minh City 25
The Dalles 25
Bremen 24
Princeton 23
Kunming 21
Leawood 21
Shanghai 20
Fremont 19
Hebei 19
Hong Kong 19
Redmond 17
Santa Clara 17
Düsseldorf 16
Tianjin 16
Changsha 15
Norwalk 15
Detroit 14
Helsinki 14
Mexico City 14
University Park 14
Guangzhou 13
Johannesburg 13
Mountain View 13
Rome 13
Shenyang 13
Andover 12
Boardman 12
Jiaxing 12
Kent 12
Nuremberg 12
San Francisco 12
Tokyo 12
Augusta 11
Lauterbourg 11
London 11
Orange 11
Phoenix 11
Simi Valley 11
Vienna 11
Warsaw 11
Washington 11
Bexley 10
Kish 10
Ankara 9
Hangzhou 9
Toronto 9
Atlanta 8
Busto Arsizio 8
Cambridge 8
Chennai 8
Rio de Janeiro 8
Almere Stad 7
Amsterdam 7
Baghdad 7
Falls Church 7
Manchester 7
Porto Alegre 7
Pune 7
Stockholm 7
Tashkent 7
Totale 4.738
Nome #
Safety and efficacy of G-CSF in patients with ischemic heart failure: The CORNER (Cell Option for Recovery in the Non-Eligible patients for Revascularization) study. 238
The HEART study: a real-world experience using the CID Chrono Carbostent in primary and rescue PCI 222
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 208
Usefulness of intracardiac echocardiography for the diagnosis of cardiovascular implantable electronic device-related endocarditis 207
Predictors of Postoperative Atrial Fibrillation in Patients with Coronary Artery Disease Undergoing Cardiopulmonary Bypass: A Possible Role for Myocardial Ischemia and Atrial Inflammation 204
A case of fatal stent thrombosis after Carbostent implantation: Is clopidogrel alone antiplatelet therapy a safe alternative to aspirin alone antiplatelet therapy 193
Predictors of postoperative atrial fibrillation in patients with coronary artery disease undergoing cardiopulmonary bypass: a possible role for myocardial ischemia and atrial inflammation 183
Patent foramen ovale and hypercoagulable state in the pathogenesis of acute thrombotic myocardial infarction 178
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 177
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 173
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study 171
Characterization of microvascular and myocardial damage within perfusion defect area at myocardial contrast echocardiography in the subacute phase of myocardial infarction 169
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study). 168
Intramural atrial hematoma: a rare complication of a common procedure 164
Post-traumatic myocardial infarction with hemorrhage and microvascular damage in a child with myocardial bridge: is coronary anatomy actor or bystander? 160
Angiographic assessment of myocardial perfusion in Tako-Tsubo syndrome 156
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 155
Influence of left ventricular hypertrophy on microvascular dysfunction and left ventricular remodeling after acute myocardial infarction 155
Thrombus aspiration reduces microvascular obstruction after primary coronary intervention: a myocardial contrast echocardiography substudy of the REMEDIA Trial 151
Coronary bifurcation lesions: to stent one branch or both? A meta-analysis of patients treated with drug eluting stents. 151
Presence of 'ghosts' and mortality after transvenous lead extraction 150
The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study 150
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function 150
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study 149
The Association Between ICD Interventions and Mortality is Independent of their Modality: Clinical Implications 146
Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis 146
Effects of late REopening of Coronary total Occlusion on micRovascular perfusion and myocarDial function: the RECORD study 145
Safety of transvenous lead extraction according to centre volume: a systematic review and meta-analysis 145
Positron emission tomography in acute coronary syndromes 142
Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients 140
Prognostic value of heart rate turbulence and its relation to inflammation in patients with unstable angina pectoris 140
Influence of the amount of myocardium subtended by a stenosis on fractional flow reserve 140
The Extent of Microvascular Damage During Myocardial Contrast Echocardiography Is Superior to Other Know Indexes of Post-Infarct Reperfusion in Predicting Left Ventricular Remodeling 139
Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis 138
Images in cardiovascular medicine. Intramyocardial spontaneous hematoma mimicking an acute myocardial infarction. 137
Presence of 'ghosts' and mortality after transvenous lead extraction 137
Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in Apical Ballooning or Tako-Tsubo Syndrome 135
Use of Levosimendan as bridge therapy to surgical correction of post-infarction ventricular septal defect: a case report 135
Myocardial infarction in isolated ventricular non-compaction: contrast echo and MRI 134
From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells 134
Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents. 134
Assessment of resting perfusion defects in patients with acute myocardial infarction: comparison of myocardial contrast echocardiography, combined first-pass/delayed contrast-enhanced magnetic resonance imaging and 99mTC-sestamibi SPECT. 133
Ethanol abolishes ischemic preconditioning in humans 131
Functional and structural correlates of persistent ST elevation after acute myocardial infarction successfully treated by percutaneous coronary intervention 131
The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial 127
Effects of late REopening of Coronary total Occlusion on micRovascular perfusion and myocarDial function: the RECORD study 123
Outcome of Patients Treated by Cardiac Resynchronization Therapy Using a Quadripolar Left Ventricular Lead 122
Reversible microvascular dysfunction coupled with persistent myocardial dysfunction: implications for post-infarct left ventricular remodelling. 121
Cardiac thrombi mistaken for metastasis in recurrent melanoma 117
[Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate)] 114
Contrast-enhanced magnetic resonance imaging and myocardial contrast echocardiography in patients with acute myocardial infarction: comparison with 99Technetium Sestamibi SPECT for the detection of perfusion defects. 113
The Multi-center Evaluation of the Accuracy of the Contrast MEdium INduced Pd/Pa RaTiO in Predicting FFR (MEMENTOFFR) Study 112
CONTRAST MEDIUM INDUCED PD/PA RATIO (CMR) VERSUS FFR AND ADENOSINE-FREE INDEXES IN THE EVALUATION OF INTERMEDIATE CORONARY STENOSIS 111
DESolve novolimus-eluting bioresorbable coronary scaffold failure assessed by frequency-domain optical coherence tomography imaging 108
Coronary slow flow is associated with a worse clinical outcome in patients with Takotsubo syndrome 107
Fractional flow reserve in acute coronary syndromes and in stable ischemic heart disease: clinical implications 101
Multiple vertebral fractures precipitate a platypnea-orthodeoxia syndrome in a patient with atrial septal defect and aortic root dilatation: when the upright position becomes intolerable 99
The Effects of Granulocyte Colony-Stimulating Factor in Patients with a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling: A 10-Year Follow-Up of the RIGENERA Study 99
Cardiogenic shock due to coronary fistula: a complex phenomenon 90
Ghostbusters should come back to lead extraction arena in order to fight with ghosts: Author's reply 90
Cardiac thrombi mistaken for metastasis in recurrent melanoma 89
Stent malapposition, strut coverage and atherothrombotic prolapse after percutaneous coronary interventions in ST-segment elevation myocardial infarction 87
temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation 86
Determinants and Evolution of Obstructive Sleep Apnea Syndrome After Myocardial Infarction 85
A pilot study with a new, rapid-exchange, thrombus-aspirating device in patients with thrombus-containing lesions: the Diver C.E. study. 82
Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study 77
Use of a second, "buddy" wire during percutaneous coronary interventions: A simple solution for some challenging situations 76
Coronary microvascular dysfunction beyond microvascular obstruction in ST-elevation myocardial infarction: Functional and clinical correlates 76
Directional atherectomy before stenting versus stenting alone in percutaneous coronary interventions: A meta-analysis. 72
Endothelin-1 and acute myocardial infarction: A no-reflow mediator after successful percutaneous myocardial revascularization 70
Sodium bicarbonate plus N-acetylcysteine to prevent contrast-induced nephropathy in primary and rescue percutaneous coronary interventions: The BINARIO (BIcarbonato e N-Acetil-cisteina nell'infaRto mIocardico acutO) study 68
Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction 64
Urgent PCI in patients with stent thrombosis: an observational single-center study comparing thrombus aspiration and standard PCI 61
The no-reflow phenomenon 59
Outcomes of the tacrolimus drug-eluting Janus stent: A prospective two-centre registry in high-risk patients 54
Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI 52
Rescue percutaneous coronary intervention for failed thrombolysis in a patient with anomalous coronary arteries 49
The complex link between oxidised low-density lipoprotein and unstable angina 46
Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation 41
Manual thrombus-aspiration improves myocardial reperfusion: The randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial 40
Angiographics evalutation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI 35
Endotelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization 24
Totale 10.091
Categoria #
all - tutte 39.276
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.276


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021367 0 0 0 0 0 19 84 20 109 18 95 22
2021/2022871 42 72 8 33 45 47 28 161 26 63 178 168
2022/20231.735 225 258 149 273 90 206 77 149 218 21 48 21
2023/2024784 29 192 44 22 32 208 27 16 22 28 94 70
2024/20251.355 27 48 100 74 158 29 19 65 190 151 301 193
2025/20261.883 562 83 179 349 682 28 0 0 0 0 0 0
Totale 10.091